Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Nie

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Nature Communications|September 4, 2024
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinomaYang Liu, Shuang-Yan Ye, Shuai He, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Nature Medicine|January 3, 2024
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trialShu-Qiang Yuan, Run-Cong Nie, Ying Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialRun-Cong Nie, Ying Jin, Cheng-Cai Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving ChemotherapyYun Wang, Yan-Yu Cai, Tobias Herold, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Nature Communications|September 4, 2024
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinomaYang Liu, Shuang-Yan Ye, Shuai He, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Nature Medicine|January 3, 2024
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trialShu-Qiang Yuan, Run-Cong Nie, Ying Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialRun-Cong Nie, Ying Jin, Cheng-Cai Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving ChemotherapyYun Wang, Yan-Yu Cai, Tobias Herold, et al.
Pageof 15